Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dawn A Fishbein"'
Autor:
Ilan Fleisher, Alexander G Geboy, Whitney Nichols, Sameer Desale, Stephen Fernandez, Peter Basch, Dawn A Fishbein
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252412 (2021)
BackgroundThere are approximately 300,000 people in the United States who are co-infected with HIV and HCV. Several organizations recommend that individuals who are HCV infected, as well as persons over the age of 13, should be HIV tested. Comorbidit
Externí odkaz:
https://doaj.org/article/574423f61404453183d735a0976b340b
Autor:
Alexander G Geboy, Whitney L Nichols, Stephen J Fernandez, Sameer Desale, Peter Basch, Dawn A Fishbein
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216459 (2019)
Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today, increasing the feasibility of disease elimination. However, large healthcare systems may not be fully prepared for supporting recommended actions due
Externí odkaz:
https://doaj.org/article/034a42a038ff4fed93bce11cacc11d28
Autor:
Dawn A Fishbein, Ian Brooks, Emanuel Villa Baca, Ozgur Ozmen, Mallikarjun Shankar, Gil Weigand, Kristina Thiagarajan, Randy Estes, Alex Geboy, Hala Deeb, Mamta Jain, Lesley Miller
Publikováno v:
Journal of Clinical and Translational Science, Vol 1, Pp 15-16 (2017)
OBJECTIVES/SPECIFIC AIMS: Hepatitis C viral (HCV) infections are rising significantly both in young adults and as newly diagnosed cases in “baby boomers.” New HCV therapeutics cure over 95% of cases, and a call has been made for elimination of th
Externí odkaz:
https://doaj.org/article/e5067e86fcb5445bb653492321363c0e
Publikováno v:
AIDS Research and Treatment, Vol 2012 (2012)
Background. Liver fibrosis is accelerated in HIV and hepatitis C coinfection, mediated by profibrotic effects of angiotensin. The objective of this study was to determine if angiotensin converting enzyme inhibitors (ACE-Is) attenuate liver fibrosis i
Externí odkaz:
https://doaj.org/article/120edb4d8687435abcc1e9ee1745fc73
Autor:
Martin Trippler, Dawn A. Fishbein, Michael A. Polis, Seerat Poonia, Joerg F. Schlaak, Shyam Kottilil, Zonghui Hu, Anu Osinusi, Susanna Naggie, Emily K. Funk, Henry Masur
Publikováno v:
Journal of Medical Virology. 84:1106-1114
Published studies have described a strong association with a single-nucleotide polymorphism (SNP) in the inosine triphosphate pyrophosphatase (ITPA) gene and ribavirin (RBV)-induced hemolytic anemia in HCV-infected patients receiving pegylated interf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::542adadd400deb7d96b57c451458c866
https://doi.org/10.1002/jmv.23302
https://doi.org/10.1002/jmv.23302
Publikováno v:
Journal of Addictive Diseases. 29:461-465
Patients with chronic hepatitis C virus (HCV) are at increased risk for complications of liver disease if they become infected with the hepatitis A (HAV) or hepatitis B (HBV) viruses. The authors examined the rates of testing for HAV, HBV, and HCV, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6eadf5a7f409ab91d4fcd38056e551
https://doi.org/10.1080/10550887.2010.509281
https://doi.org/10.1080/10550887.2010.509281
Autor:
Douglas T. Dieterich, Dawn A. Fishbein, Laveeza Bhatti, Matthew B. Goetz, Kalvin Yu, Jeffrey J. Weiss, Glenn J. Wagner, Brian R. Edlin
Publikováno v:
Alimentary Pharmacology & Therapeutics. 28:289-293
Aliment Pharmacol Ther 28, 289–293 Summary Background Prior research on adherence to hepatitis C treatment has documented rates of dose reductions and early treatment discontinuation, but little is known about patients’ dose-taking adherence. Aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cadf4447e077cf9a0ee7472c0f08a3ef
https://doi.org/10.1111/j.1365-2036.2008.03718.x
https://doi.org/10.1111/j.1365-2036.2008.03718.x
Autor:
Dawn A Fishbein, Irina Barash, Mary E. Klotman, Alan J. Cohen, Christina M. Wyatt, Carlos D Malvestutto, Paul E. Klotman, Jonathan A. Winston
Publikováno v:
AIDS. 21:2101-2103
Kidney disease is an important complication of HIV, particularly in minority populations. We describe the burden of chronic kidney disease among 1239 adults followed at an urban AIDS center, with an estimated prevalence of 15.5% (n = 192). Independen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3048680656e47f2dbb7c6c7dc78e5e60
https://doi.org/10.1097/qad.0b013e3282ef1bb4
https://doi.org/10.1097/qad.0b013e3282ef1bb4
Autor:
Anu Osinusi, Gebeyehu Teferi, Dawn A. Fishbein, Dana Silver, Rhiannon N. Silk, Sarah Henn, Geeta S. Karnik, Shyam Kottilil, Lara Stabinski, Leleka Doonquah, Henry Masur
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 56(9)
Degree of liver fibrosis largely determines treatment urgency for hepatitis C virus (HCV). This retrospective study examined fibrosis stages and predictive factors in African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ae435429cd6d17b6b2a547e51cde84c
https://pubmed.ncbi.nlm.nih.gov/23378283
https://pubmed.ncbi.nlm.nih.gov/23378283
Publikováno v:
AIDS Research and Treatment
AIDS Research and Treatment, Vol 2012 (2012)
AIDS Research and Treatment, Vol 2012 (2012)
Background. Liver fibrosis is accelerated in HIV and hepatitis C coinfection, mediated by profibrotic effects of angiotensin. The objective of this study was to determine if angiotensin converting enzyme inhibitors (ACE-Is) attenuate liver fibrosis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27864ea6a14f94fa233a2de7a8a0116c